Speaker illustration

Doctor Yukihiro Koretsune

Osaka National Hospital, Osaka (Japan)

The global ETNA-AF registry programme: snapshot baseline demographics and patient characteristics from more than 17,700 atrial fibrillation patients on edoxaban

Event: ESC Congress 2018

Topic: Clinical

Session: Atrial fibrillation - Stroke Prevention

Thumbnail

This platform is supported by

logo Novo Nordisk